Evidence map›Paper›PMID 27403940›Full record

ArticleScientific reports2016

Viral Evolution and Cytotoxic T Cell Restricted Selection in Acute Infant HIV-1 Infection.

Miguel A Garcia-Knight, Jennifer Slyker, Barbara Lohman Payne, Sergei L Kosakovsky Pond, Thushan I de Silva, Bhavna Chohan, Brian Khasimwa, Dorothy Mbori-Ngacha, Grace John-Stewart, Sarah L Rowland-Jones and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Miguel A Garcia-KnightNuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
Jennifer SlykerDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.
Barbara Lohman PayneDepartment of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Sergei L Kosakovsky PondDepartment of Medicine, University of California San Diego, San Diego, California, United States of America.
Thushan I de SilvaSection of Paediatrics, Department of Medicine, Wright Fleming Institute, Imperial College London, London, United Kingdom.
Bhavna ChohanDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.
Brian KhasimwaKenyan Medical Research Institute, Nairobi, Kenya.
Dorothy Mbori-NgachaDepartment of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya.
Grace John-StewartDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.
Sarah L Rowland-JonesNuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
Joakim EsbjörnssonNuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
University of Washington · USKenya Medical Research Institute · KEUniversity of Oxford · GBImperial College London · GBKarolinska Institutet · SEUniversity of California, San Diego · USUniversity of Nairobi · KE

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
Urgent Versus Post-Stabilization ART in HIV+ Children with Severe Co-infectionsR01HD023412 · NICHD · UNIVERSITY OF WASHINGTON · PI Grace C. John-Stewart, DALTON CHEKOKO WAMALWA · 1987 to 2026
$12.2M
Modeling Epidemic Infectious Diseases Using Sequence AnalysisU01GM110749 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI POND, SERGEI L KOSAKOVSKY · 2014 to 2018
$3.0M
HyPhy: Molecular Evolutionary AnalysesR01GM093939 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI MUSE, SPENCER V., POND, SERGEI L KOSAKOVSKY · 2010 to 2018
$2.5M
Pediatric HIV-1 in Africa: Pathogenesis and ManagementK24HD054314 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C. · 2006 to 2016
$1.2M
NIAID NIH HHS P30 AI027757NICHD NIH HHS K24 HD054314NICHD NIH HHS R01 HD023412NIGMS NIH HHS R01 GM093939NIGMS NIH HHS U01 GM110749Wellcome Trust 089567/Z/09/Z
6 · The paper itself

Abstract

Antiretroviral therapy-naive HIV-1 infected infants experience poor viral containment and rapid disease progression compared to adults. Viral factors (e.g. transmitted cytotoxic T- lymphocyte (CTL) escape mutations) or infant factors (e.g. reduced CTL functional capacity) may explain this observation. We assessed CTL functionality by analysing selection in CTL-targeted HIV-1 epitopes following perinatal infection. HIV-1 gag, pol and nef sequences were generated from a historical repository of longitudinal specimens from 19 vertically infected infants. Evolutionary rate and selection were estimated for each gene and in CTL-restricted and non-restricted epitopes. Evolutionary rate was higher in nef and gag vs. pol, and lower in infants with non-severe immunosuppression vs. severe immunosuppression across gag and nef. Selection pressure was stronger in infants with non-severe immunosuppression vs. severe immunosuppression across gag. The analysis also showed that infants with non-severe immunosuppression had stronger selection in CTL-restricted vs. non-restricted epitopes in gag and nef. Evidence of stronger CTL selection was absent in infants with severe immunosuppression. These data indicate that infant CTLs can exert selection pressure on gag and nef epitopes in early infection and that stronger selection across CTL epitopes is associated with favourable clinical outcomes. These results have implications for the development of paediatric HIV-1 vaccines.

Indexed as

Evolution, MolecularChild, PreschoolDisease ProgressionFemaleGenes, gagGenes, polHIV-1HIV InfectionsHumansInfantnef Gene Products, Human Immunodeficiency VirusT-Lymphocytes, Cytotoxicnef Gene Products, Human Immunodeficiency Virus

Identifiers

PMID27403940
PMCPMC4941567
OpenAlexW2464024463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.